Business

Court overturns patent decision against Johnson & Johnson

Advertisement

WASHINGTON — A US appeals­ court ruled that a Johnson & Johnson heart stent does not infringe on a patent held by a doctor and an inventor, overturning a $482 million verdict against the company. The three-judge panel said a lower court misinterpreted the company’s patent and should not have ruled in favor of Dr. Bruce Saffran­ of Princeton, N.J.

Heart stents are mesh-wire tubes that prop open arteries affected by coronary artery disease. The dispute centered on drug-eluting stents, which release a drug to help keep arteries­ from clogging.

Saffran sued J&J in 2007, alleging its Cypher stents infringed on his 1997 patent covering technology to deliver medication inside the body. A Texas jury ruled in Saffran’s favor in 2011, concluding that J&J had willfully infringed on his patent.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com